BIOMAT Database Logo BIOMAT Database Logo

[Typhoid and paratyphoid fever]. 2020

Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Bereich Infektions- und Tropenmedizin, Klinik und Poliklinik für Gastroenterologie, Hepatologie, Infektiologie, Pneumologie, Universitätsklinikum Leipzig.

Typhoid fever and paratyphoid fever are systemic infectious diseases of global significance caused by Salmonella enterica subspecies enterica Serovar Typhi (short name: Salmonella Typhi) or Serovar Paratyphi (short name: Salmonella Paratyphi). The course of these fecal-orally transmitted diseases is mainly characterized by a high fever. Left untreated, the course of typhoid fever can be severe and lethal. The infection is almost always acquired outside of Europe (mainly in India) and is notifiable in Germany, Austria and Switzerland. Paratyphoid is an attenuated disease of typhoid fever caused by Salmonella Paratyphi. Available vaccines only protect against Salmonella Typhi. Antibiotic resistance reflects the situation in endemic countries and shows a worrying increase of multi-drug resistant isolates. Currently, third-generation cephalosporins such as ceftriaxone are recommended as first-line therapy; if sensitive to quinolones, fluoroquinolones such as ciprofloxacin may continue to be administered. Crucial preventive measures for travelers to endemic regions include consistent water and food hygiene as well as vaccination, whereby only protection rates of 50-70 % are achieved by currently available vaccines. In the light of increasing multi-drug resistance, a more effective conjugate vaccine against Salmonella Typhi with cross-reactivity against Salmonella Paratyphi is needed more than ever.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010284 Paratyphoid Fever A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe. Fever, Paratyphoid,Fevers, Paratyphoid,Paratyphoid Fevers
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012482 Salmonella paratyphi A A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans. Salmonella paratyphi,Salmonella enterica serovar Paratyphi A
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D014435 Typhoid Fever An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA. Enteric Fever,Typhus, Abdominal,Salmonella typhi Infection,Typhoid,Abdominal Typhus,Enteric Fevers,Fever, Enteric,Fever, Typhoid,Fevers, Enteric,Fevers, Typhoid,Infection, Salmonella typhi,Infections, Salmonella typhi,Salmonella typhi Infections,Typhoid Fevers,Typhoids
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D018074 Vaccines, Conjugate Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. Conjugate Vaccine,Conjugate Vaccines,Vaccine, Conjugate

Related Publications

Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
[Typhoid fever--paratyphoid fever].
January 1999, Ryoikibetsu shokogun shirizu,
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
January 2014, The Alabama nurse,
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
[Typhoid and paratyphoid fever].
February 2003, Nihon rinsho. Japanese journal of clinical medicine,
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
January 2005, Lancet (London, England),
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
November 2005, Lancet (London, England),
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
November 2005, Lancet (London, England),
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
November 2005, Lancet (London, England),
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
Typhoid and paratyphoid fever.
September 1979, Clinics in gastroenterology,
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
[Typhoid and paratyphoid fever].
March 2007, Nihon rinsho. Japanese journal of clinical medicine,
Henning Trawinski, and Sebastian Wendt, and Norman Lippmann, and Sascha Heinitz, and Amrei von Braun, and Christoph Lübbert
[Typhoid fever . paratyphoid fever, cholera].
November 2001, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!